References
- Lokich JJ, Bothe A, Fine N, Perri J. Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 1981; 48: 2565–2566
- Wade JL, Herbst S, Greenburg A. Prolonged venous infusion (PVI) of 5-fluorouracil (5-FU) for metastatic colon cancer (MCC)–a follow-up report (Abstr). Proc Am Soc Clin Oncol 1988; 7: 94
- Hansen E, Quebbeman R, Aussman R, et al. Continuous 5-fluorouracil (5-FU) infusion in colorectal cancer. Update of the MCW experience (Abstr). Proc Am Soc Clin Oncol 1987; 6: 80
- Molina R, Fabian C, Slavik M, Dahlberg S. Reversal of palmarplantar erythrodysesthesia (PPE) by B6without loss of response in colon cancer patients receiving 200 mg/m2/day continuous 5-FU (Abstr). Proc Am Soc Clin Oncol 1987; 6: 90
- Lokich JJ. Colorectal cancer. Cancer Chemotherapy by Infusion., JJ Lokich. Precept Press, Chicago 1987; 291–303
- Belt RJ, Davidven ML, Myron MC, Barrett S. Continuous lowdose 5-fluorouracil (5-FU) for adenocarcinoma: confirmation of activity (Abstr). Proc Am Soc Clin Oncol 1985; 4: 90
- Leichman L, Leichman CG, Kinzie J, et al. Long-term low-dose 5-fluorouracil (5-FU) in advanced measurable colon cancer: no correlation between toxicity and efficacy (Abstr). Proc Am Soc Clin Oncol 1985; 4: 86
- Benedetto P, Davida E, Soloman J. Chronic continuous systemic infusion 5-fluorouracil (CCI-5-FU) in the treatment of metastatic colorectal carcinoma (CCA) (Abstr). Proc Am Soc Clin Oncol 1984; 3: 142
- Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusional 5-fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A MidAtlantic Oncology Program study. J Clin Oncol 1989; 7: 425–432
- Schabel FM, Jr., Trader MW, Laster WR, Jr, et al. Cis-dichlorodiammineplatinum (II): Combination chemotherapy and cross resistance studies with tumors of mice. Cancer Treat Rep 1979; 63: 1459–1473
- Bergerat JP, Green C, Drewinko B. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations usingcis-diamminedichloroplatinum. Cancer Biochem Biophys 1979; 3: 173–180
- Ortiz J, Woolley PV. A study of the synergistic cytotoxic effects of 5-fluorouracil and cisplatin against colon carcinoma cells using median effect analysis (Abstr). Proc Assoc Cancer Res 1987; 28: 414
- Cantrell JE, Hart RD, Taylor RF, Harvey JC. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer. Cancer Treat Rep 1987; 71: 615–618
- Lokich J, Cantrell J, Ahlgren J, Phillips J. A phase II trial of protracted infusional 5-FU (PIF) vs PIF plus weekly bolus cisplatin (CDDP) in advanced measurable colon cancer (MAOP protocol 5286) (Abstr). Proc Soc Clin Oncol 1989; 8: 104
- Lokich JJ, Moore C. Chemotherapy associated palmar-plantar erythsodysesthesia syndrome. Ann Intern Med 1984; 101: 798–800
- Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- Kish J, Drelichman A, Jacobs J, et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471–474
- Amrein PC, Wietzman SA. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 1985; 3: 1632–1639
- Hilgenberg AD, Carey RW, Wilkins EW, Jr, et al. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 357–363
- Weiden PL, Einstein AB, Rudolph RH. Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer. Cancer Treat Rep 1985; 69: 1253–1255
- Loehrer PJ, Turner S, Kubilis P, et al. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer. A Hoosier Oncology Group trial. J Clin Oncol 1988; 6: 642–648
- Richards F, II, Beck J, Muss H, et al. Continuous infusion 5-fluorouracil (5-FU) with bolus cisplatin (P) in the treatment of metastatic colorectal cancer (Abstr). Proc Am Soc Clin Oncol 1988; 7: 96